igvf:replacement_of_2ba01755-df67-453b-b047-f7cdba236665
jesse-engreitz:modification-teloHAEC-dCas9-KRAB
This Crispr Modification is an identical replacement of the previously submitted Modification 2ba01755-df67-453b-b047-f7cdba236665. Doxycyline treatment was done only for the purpose of activating the domain